Ronald Bentsur
Chief Executive Officer at NUVECTIS PHARMA, INC.
Net worth: 21 M $ as of 29/04/2024
Ronald Bentsur active positions
Companies | Position | Start | End |
---|---|---|---|
NUVECTIS PHARMA, INC. | Chief Executive Officer | 26/07/2020 | - |
Chairman | 26/07/2020 | - | |
Founder | 26/07/2020 | - | |
President | 26/07/2020 | - | |
BEYOND AIR, INC. | Director/Board Member | 31/07/2015 | - |
Independent Dir/Board Member | 31/07/2015 | - | |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Director/Board Member | 31/12/2016 | - |
Chairman | 31/07/2015 | 31/12/2016 | |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Chairman | 31/07/2015 | - |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - | - |
Career history of Ronald Bentsur
Former positions of Ronald Bentsur
Companies | Position | Start | End |
---|---|---|---|
STEMLINE THERAPEUTICS, INC. | Director/Board Member | 31/12/2008 | 31/05/2020 |
UROGEN PHARMA LTD. | Director/Board Member | 30/09/2015 | 02/01/2019 |
Chief Executive Officer | 31/07/2015 | 02/01/2019 | |
KERYX BIOPHARMACEUTICALS | Director/Board Member | 15/06/2009 | 29/04/2015 |
Chief Executive Officer | 19/05/2009 | 29/04/2015 | |
XTL BIOPHARMACEUTICALS LTD. | Chief Executive Officer | 31/12/2005 | 31/03/2009 |
░░░░░ ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Ronald Bentsur
The Hebrew University of Jerusalem | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
Israel | 8 |
United States | 6 |
2 |
Operational
Director/Board Member | 6 |
Chief Executive Officer | 4 |
Chairman | 3 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
XTL BIOPHARMACEUTICALS LTD. | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
NEXTGEN BIOMED LTD | Health Technology |
BEYOND AIR, INC. | Health Technology |
Private companies | 7 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Health Technology |
Leumi Partners Underwriters Ltd. | |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Ait Ltd. engages in research and development in biotechnology. The private company is located in Israel. The Israeli company was founded by Yossef Av-Gay, Amir Avniel, Avishai Abrahami. Amir Avniel has been the CEO of the company since 2011. | Health Technology |
Nuvectis Pharma, Inc. | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
- Stock Market
- Insiders
- Ronald Bentsur
- Experience